Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00797680 · ClinicalTrials.gov registry record · Phase 2
Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT00797680 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 34 participants.
The verdict
NCT00797680, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
In this study, children who survive cardiac arrest will be evaluated whether 24 or 72 hours of whole body hypothermia (cooling) during recovery is better to help prevent brain injury and improve outcome. The investigators will also test the safety of cooling patients for 24 and 72 hours. The investigators hypothesize that 72 hours of cooling will be more beneficial than 24 hours without compromising safety.
Interventions
- OTHER 72 hours hypothermia
- OTHER 24 hours hypothermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-10 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00797680
The ClinicalTrials.gov registry entry for NCT00797680 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 72 hours hypothermia is the first listed.
NCT00797680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00797680 about?
NCT00797680 is a clinical study titled "Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest". In this study, children who survive cardiac arrest will be evaluated whether 24 or 72 hours of whole body hypothermia (cooling) during recovery is better to help prevent brain injury and improve outcome. The investigators will also test the safety of cooling patients for 24 and 72 hours. The investi...
What is the current status of trial NCT00797680?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2008-10. Estimated completion is 2015-04.
What interventions are being tested in trial NCT00797680?
The interventions under investigation include: 72 hours hypothermia (OTHER), 24 hours hypothermia (OTHER).
Who is sponsoring clinical trial NCT00797680?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.